Ryvu Therapeutics S.A. (WSE:RVU)
Poland · Delayed Price · Currency is PLN 15.38
-0.02 (-0.13%)
Jun 12, 2026, 5:00 PM CET
Ryvu Therapeutics Market Cap
Ryvu Therapeutics has a market cap or net worth of 355.59 million as of June 12, 2026. Its market cap has decreased by -51.17% in one year.
Market Cap
355.59M
Enterprise Value
368.51M
Revenue
88.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.38
Market Cap Chart
Since July 14, 2011, Ryvu Therapeutics's market cap has increased from 56.50M to 355.59M, an increase of 529.32%. That is a compound annual growth rate of 13.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 355.59M | -43.25% |
| Dec 30, 2025 | 626.56M | -29.61% |
| Dec 30, 2024 | 890.13M | -33.04% |
| Dec 29, 2023 | 1.33B | 16.75% |
| Dec 30, 2022 | 1.14B | 1.70% |
| Dec 30, 2021 | 1.12B | 23.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Captor Therapeutics Spolka Akcyjna | 489.21M |
| Bioceltix | 486.29M |
| BIOTON | 343.46M |
| Syn2bio | 285.01M |
| Synthaverse | 206.10M |
| Mabion | 116.37M |
| Molecure | 112.91M |
| Poltreg | 111.23M |